Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Mitsubishi UFJ Financial Group Inc. Common Stock (MUFG) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade
Mitsubishi UFJ Financial Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Ionis Pharmaceuticals Inc. Common Stock vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $21.68 (market cap $247.53B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 34.9× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.46% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 2 Days on average.

IONSMUFG
Market Cap
$7.10B$247.53B
Volume
2,027,4573,196,989
Sector
HealthFinancials
52-Week High
$86.50$24.13
52-Week Low
$42.38$14.77
Typical Hold Time
0 Days2 Days
Enterprise Value
$6.66B$28.41T
Dividend Yield
—2.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Mitsubishi UFJ Financial Group Inc. Common Stock

MUFG trades at $22.40, up 0.22% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.45 exceeding the $0.35 estimate. Fundamentals show robust profitability with a 34.22% net income margin and 12.6% ROE, while valuation ratios like a P/E of 14.99 appear reasonable. Recent news highlights a partnership with SkyDrive for eVTOL feasibility studies and positive analyst momentum coverage.

The outlook is supported by earnings momentum and a 100% buy rating from analysts, but risks include a high debt-to-asset ratio of 5.81 and significant negative cash flow trends. Investor sentiment is optimistic due to strong quarterly results and institutional interest, though technical weakness and macroeconomic sensitivity pose near-term challenges.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONS
100% Buy0% Sell
Avg holding period · 0 Days
MUFG
100% Buy0% Sell
Avg holding period · 2 Days

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →

About Mitsubishi UFJ Financial Group Inc. Common Stock

Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.

Read more on MUFG →